Professional Documents
Culture Documents
9.
D - no age
restriction on the
elderly as long as
written
permission from
MD or blood
bank attending
2.
10.
3.
C - without
complications, a
unit will increase
platelet count
from 510,000/uL.
15+30,000/60,000
= 45-75,000/uL
11.
B - Initials are
needed on req
or tube, not
both, but date is
needed on tube.
12.
13.
A - DCE/dCE
does not express
c or e
14.
D - general physical
requirements are: 50-100
bpm, temp < 37.7 deg, bp <
180/100, hgb >/= 12.5 g/dL.
Exceptions for pulse can be
made for athelets as long
as no irregularities are
detected
15.
D - do not issue
additional units
until reaction has
been
investigated.
16.
C - destroy the
unit
17.
B - prevents
GvHD, CMV
transmission
4.
5.
6.
7.
8.
18.
C - the
sudden rise
in
temperature
signifies
bacterial
sepsis.
19.
B - check
previous BB
records.
Then
proceed to C
immediately
and request
a patient
sample.
20.
Bcomplement
cascade
21.
C - rouleaux
would not
occur in AHG
phase b/c all
serum has
been
washed
away. The
autocontrol is
negative.
24.
25.
D - can only
develop antiD as a
alloantibody
22.
23.
26.
27.
B - Bg(a) corresponds
with HLA-B7, Bg(b)
corresponds with HLAB17, Bg(c) corresponds
with HLA-A28
28.
B - gel test
29.
30.
C - underwashing can
cause reagent
neutralization by free
AHG
31.
B - suggests coating of
RBCs
32.
33.
Before intrauterine
transfusion, what prep does
the unit need to go through
before transfusio? (a) Add FFP
and pool-ed plasma (b) Check
that the RBC group in
consistent with the fathers
group (c) irradiate the RBCs (d)
Test the RBCs with neonatal
eluate
C - needs to be irradiated
to prevent GvHD. A
minimum of 25 Gy
delivered to midplane and
15 Gy to all other areas.
35.
36.
37.
D - percent yield =
(250300,000)/(450200,000)
= 83%
39.
D - percent yield =
(50900,000)/(250300,000)
= 60%
40.
D - although usually
associated with IgM, CHD
is generally caused by C3
binding to cells and IgM
binding to C3 in
extremities at lower
temperature.
34.
38.
41.
42.
43.
C - D could be any
antibody
44.
B - can be done by
electronic
crossmatch, basic
(IS), or extended (IS,
37, AHG) for positive
antibody screens
45.
D - AT3 is found in
FFP and commercial
sources and is used
to treat liver disease,
DIC, and
thromboembolic
disorder.
Cryoprecipitate
contains: F8:c, F8:vW,
F13, Fibrinogen,
Fibronectin, VWF,
cryoglobulin.
46.
47.
C - passive anti-D is
most likely still in
maternal blood from
the RhIG
administration.
48.
C - patients cannot
donate with aspirin
ingestion </= 36 hrs.
B - represents
hemolysis. Also
look for
haptoglobin
decrease and
hemoglobinuria.
50.
B - excess ab
causes ration
ag:ab to be small
51.
B - failure to
wash off free
human globulin,
which can
neutralize AHG.
C - increase
plasma volume.
Helps to
neutralize lactic
acid, a product
of anaerobic
glycolysis.
D - O blood
group already
have anti-A and
anti-B.
C - positive DAT
would help
resolve
discrepancy.
56.
C - ABO
antibodies are
not generally
included
57.
B - IgG that
react at LISS
and albumin
49.
52.
53.
54.
55.
58.
59.
60.
61.
62.
63.
64.
B - need to calculate
frequency of antigen
negative units
(.23*.9) and then
divide the units by
this number (2/.21).
65.
66.
A - DAT
67.
D - 1% of RBCs are
cleared each day
68.
69.
70.
D - Indicates D pos
and D neg cell
populations. A FMH
(rosette) and KB
test should be done
on the mothers
blood and RhoGAM
administered if
necessary
A - Infectious
disease's
A - partial D
individuals are
missing one or more
epitopes and will
not recognize a full
D epitope as their
own.
B - platelet count
needs to 5.5e10 plts,
this count yields
4.5e10 plts (50
mL900000
plts/uL1000uL/mL)
A - could be false
negative
73.
C - genetic material
provided from each
parent
74.
B - warm auto
reacting at AHG
would have a
positive DAT and
would need to be
eluted before a
panel is run.
71.
72.
75.
76.
D - plasma
components,
group AB is
universal donor
77.
C - A,B,H only
produced by
secretors (Se).
Le(b) only
produced by Le,
Se patients
78.
79.
80.
81.
82.
B - increase time
and/or RPM
when percent
yield is low
83.
C - in PCH, cold
anti-P antibodies
bind cells at 4
deg and lyse cells
at 37 due to
complement
activation.
control cells or
cells in a patient
with CHD should
not lyse at 37
deg.
84.
85.
D - antibody coating
cells may be maternal
and not found in
serum. Eluate, in lieu
of maternal blood,
would offer the
availability of both
antibody sources.
D - rarely get
suspended in button
form
86.
87.
88.
89.
D - would
react at
coombs
phase
90.
91.
A - Yes.
Total IU F8
needs to be
above 80
IU. Final IU
= 9 IU/mL *
10 mL = 90
IU
92.
A - 50ug for
early
termination
93.
C - need to
perform KB
test for
dosage.
94.
B - full dose
for postpartum
weak D
infant
95.
B - full postpartum
dose for D
pos twin
96.
B - passive
anti-D from
previous
RhIG
97.
B - full postpartum
dose for D
pos infant
98.
B - always
administer
RhIG if
infant Rh is
in question.
99.
101.
D - KB%50 =
milliliters
bleed.
1.3%50 =
65mL
102.
C - 65mL/30
= 2.2, round
up to 3
bottles
103.
B - Allows for
BV
replacement.
104.
105.
A - needs to
be
compatible.
Only a small
percentage
of the
population
will produce
antibody
A male trauma victim is type AB, Dnegative, antibody screen neg, and will
need a large amount of blood, what should
be given next taking inventory into
account? (a) 30 units, group O, D pos (b) 26
units, group A, D pos (c) 10 units, group O,
D neg (d) 5 units, group A, D neg
B - because
male,
antibody
screen in
negative, risk
anti-D to not
deplete Dneg units
100.
106.
107.
108.
An MD delivers an unlabelled
specimen to the lab, one should: (a)
discard the specimen (b) label
specimen with MD provided
instructions (c) label specimen with
data from transfusion record (d)
request the specimen be returned to
nursing station for labelling
109.
110.
A - major
incompatibility
111.
C - All sites on
neonatal RBCs
are being blocked
by maternal antiD. A gentle heat
elution or
cloroquine
diphosphate
could resolve
discrepancy.
112.
113.
114.
B - Child 1 is
K(0)K, child 2 is
K(0)k. MacLeod
expresses weak
Kk, no cis-Kk
exists.
115.
116.
C - Jka often
declines to low
levels in serum
and may be
undetectable in
an antibody
screen.
Intravascular
delayed
hemolytic
transfusion
reaction is
characteristic of
Kidd antibodies.
118.
C - A and B are
r/o by negative
maternal ab
screen. D is r/o
because baby is
O and does not
have A or B
antigen sites.
119.
D - emergency
release
procedure
B - could cause
severe DTR.
Need compatible
units.
C - most likely
DHTR due to
surgery.
117.
120.
121.
122.
A - the autoantibody
anti-e would be hard to
find units for (80% of
pop is e+). Anti-Jk(a) can
evade titers and Jk(a)blood takes priority.
The autoantibody will
destroy donor cells at
the same rate as
current patient cells,
but the allo cold cause
HTR.
123.
D - anti-E reacts at 37
deg
124.
C - cephalosporin
antibodies will
generally not react with
RBCs unless the RBCs
have been treated with
cephalosporin. Eluate
should cause the same
result as untreated
crossmatch. Only
perform eluate if
patient has also been
recently transfused
also.
125.
126.
127.
128.
129.
130.
131.
132.
A patient is on methyldopa
therapy and has an 3+ DAT
positive and anti-e has been ID'd.
Patient has not been recently
transfused. How would you
determine whether it is an auto
and an alloantibody? (a) type
patients cells with low-protein
anti-e reagent (b) perform
autoabsorption (c) absorb the
eluate with R2R2 RBCs (d) absord
the eluate with rr RBCs
A - autoantibodies
target the patients own
RBCs. A low-protein
anti-e should be
negative.
A - crossmatch should
go to coombs
133.
A - induced
WAIHA that
reacts with all
panel cells.
134.
D - in vivo
positive DAT
represents
autoantibody
and negative
screen r/o
allo's.
135.
B - patient is
most likely
bombay
phenotype
136.
C - patient is
bombay
phenotype
b/c of positive
AHG (no
serum left).
137.
138.
D - Sufficient
volume can
be
withdrawn
from
segments.
139.
B - Identify
the infected
donor and
exclude all
units from
distribution.
141.
142.
143.
140.
144.
145.
146.
147.
148.
149.
150.
C - 1-10 deg
celcius
151.
D - provides
control check and
a check that weak
expression will be
positive
152.
A - looks for
coated cells in
vivo
153.
154.
D - Duffy is
destroyed by
enzyme, as is MNS,
Xg.
D - Both forward
and reverse
testing is in
question. Release
O neg to a female
of childbearing
age following
emergency
release protocol.
155.
D - IgG reacting at
LISS and albumin
156.
D - rewrite as
DCE/DcE
157.
A - need to
induce weak
binding
158.
D - Usually broad
Rh specificity, but
most often
associated with antie. Rh(null) may be
less likely to develop
WAIHA
159.
160.
B - RCe/RCe
exposed to
RcE/RcE
B - heart failure
caused by severe
anemia can occur
within the first few
hours of life.
A and C
A - Certain individuals
are genetically
deficient in IgA and will
have anti-IgA in their
plasma. Must receive
washed or frozenthawed RBCs from IgA
deficient donors.
A - saline replacement
166.
167.
168.
161.
162.
163.
164.
165.
169.
170.
D - FFP contains
F2,5,7,9,10
171.
A - platelets are
generally needed
during hemorrhagic
episode.
172.
C - Cryo contains
vWF, fibrinogen,
fibrinectin, F8, and
F13.
173.
174.
C - Cryo contains
vWF (F8:C, F8:vW),
fibrinogen,
fibrinectin, F8, and
F13.
175.
C - Crossmatch is
performed by using
donor RBCs and
recipient plasma.
176.
177.
A - unbound cells go
right through
suspension while
bound cells get
trapped in
suspension
178.
B - results from
decrease in RBC
viability. K, Hgb, and
ammonia increase.
Na, pH, and 2,3-BPG
decrease. Due to
decrease in ATP.
179.
D - front/back
discrepancy. Patient
could be A2B, r/o
with lectin testing
180.
181.
183.
184.
D - RBCs
C - steroids decrease
autoantibody
production.
Transfusion generally
increases autoantibody
production and RBC
destructio happens as
quickly to donor cells as
it does to patient cells.
187.
188.
B - febrile transfusions
are usually brought on
by HLA and
granulocyte-specific
antigens.
182.
185.
186.
189.
C - discontinue and
keep the IV open so
medication may be
given to counter
transfusion reaction.
190.
C - generally occur in
high-stress/highvolume areas
191.
C - transfusion may be
necessary, although
not advised. Auto's can
mask allo's easily and
could cause
transfusion reaction
and decrease oxygen
carrying capacity of
transfused cells.
192.
193.
D - no antibody
production. All
antibodies would be
maternal
194.
D - no antibody
production leaves
negative backtyping.
195.
C - patient is type A
with acquired B
antigen
196.
C - false reaction in B
forward
197.
A - positive backtyping
due to IgM
198.
199.
A - agglutination in all
backtyping due to plasma
protein presence
200.
B - low-protein reagents
exclude the change of
results being caused by a
positive DAT. Washed cells
eliminate the change of
MM. Wash with warm
saline and then use DTT
(destroys IgM).
201.
202.
203.
D - Perform tests to
identify discrepancy.
204.
205.
206.
C - Unexpected ab's
should be separated
from RBC and label with
antibody ID'd.
Transfusing plasma can
cause decreased RBC
survival. Plasma may be
used for reagent usage,
but not for transfusion.
207.
208.
209.
D - HbF is resistant to
acid elution. Stain
with erythrosin and
hematoxylin and fetal
cells appear bright
pink. count the
amount of fetal cells
per 2000 maternal
cells and multiply by
maternal BV to get
fetal bleed.
219.
220.
221.
B need heterozygous
Cc and homozygous
ee. D genotyope
unknown
222.
223.
C - by temperature,
chemical, or pH
changes
224.
225.
B - and aggitated
226.
A - adenine improves
in vitro viability
during storage by
allowing continual
generation of ATP.
227.
D - only suspension
prep is needed
228.
215.
216.
B - low 2,3-BPG
increases RBC affinity
for O2. plasma K+
increases, not RBC K+.
C - anti-Jk(a) is weak,
labile, and often goes
undetected in
pretransfusion testing.
Kidd antibodies are
often IgG, warm
reacting, and
complement
dependent.
229.
D - GH recipient. Due to
possible CJD
transmission.
217.
230.
218.
210.
211.
212.
213.
214.
232.
233.
234.
231.
235.
236.
237.
238.
A - leuko-reduced
platelets are the best for
leukemic patients with
plts < 20,000 uL.
239.
C - leuko-reduced RBCs
are needed to be </=
5e6 to avoid febrile
episodes, CMV
transmission, GvHD, or
patient
alloimmunization by
leuks.
240.
D - WAIHA from
methyldopa will rapidly
correct after cessation of
drug.
241.
242.
243.
244.
245.
255.
C - major
incompatibility
246.
B - Chido and
Rodgers are pieces
of complement C4
256.
D - Only
transplacental Ig
257.
247.
D - Lewis is IgM
248.
B - saline is the
only acceptible
product. Ringer's
causes small clots.
5% dextrose
causes RBC lysis.
258.
B - could be c or K,
but c antigen is
much higher
frequency (80% vs
10%)
259.
260.
261.
C - amniocentesis
is only peformed
when clinically
indicated. As early
as 14 weeks.
262.
D - only necessary
after positive DAT
warrants antibody
work up
263.
D - unnecessary,
need to provide O
neg cells b/c of the
maternal antibody
source. Do not
really care about
babies type.
264.
B - Kidd, I, Lewis,
Rh, ABO, P1 are
enhanced by
enzyme
265.
D - hypo may
cause no
backtyping also
249.
250.
251.
C - lewis is
absorbed onto
RBC membranes.
Pregnant women
have increase RBC
mass and can
appear to be Le(ab-) .
D - Need to have a
negative control.
Patient cells +
albumin (or patient
serum autocontrol).
252.
253.
D - hematocrit
needs to be >/=
38%
D - FFP contains
clotting factors
only. Platelets are a
cellular element
and need to be
stored at 20-24 deg
Celcius.
254.
266.
C - reacts at RT
saline. The others
go to AHG.
278.
267.
C - ant-Le(a) is not
a cell membrane
and can be
absorbed in the
serum
279.
268.
D - fucose is a
precursor to all A,B
antigens. Galactose
will lead to A antigen.
N-acetylgalactosamine
will lead to B antigens
280.
269.
A - Only D-negative
units need to be
confirmed
270.
A - all Kell
associated
substances are
expressed weakly
281.
271.
272.
D - remember
DMX (Duffy, MNSs,
Xg)
282.
273.
274.
C - PPF is pooled
and heated at 60
deg Celcius for
10hrs. Virtually no
chance of viral
transmission.
283.
DO>B>A2>A2B>A1>A1B
284.
D - these three
antibodies are often
non-RBC stimulated
antibodies.
285.
276.
D - No relation to
Fy(a-b-). 99% of
black people are
U+. 100% of whites
are U+.
277.
C - Kp(a) is only
reported in whites
286.
D - Hepatitis immunity
would not tell you
anything
287.
A - CMV is exclusively
found inleukocytes
275.
288.
Which will cause an incompatible major crossmatch? (a) Pt A pos, Donor A neg (b)
Pt A pos, Donor O pos (c) Pt A pos, Donor AB pos (d) Pt A neg, Donor A pos (e) Pt A
neg, Donor O pos
289.
Which would not indicate antibody presence? (a) positive crossmatch (b) positive
ab screening (c) rouleaux (d) forward/reverse typing discrepancy
290.
A white female's RBC's have phenotype: D+C+E-c+e+, which genotype is most likely?
(a) DCe/Dce (b) DCe/dce (c) DCe/DcE (d) Dce/dCe
291.
Why is serum containing anti-k very rare? (a) most people are k+ (b) most people are
k- (c) k antigen is not a good immunogen (d) Kell(null) people are rare
292.
Why might a patient not be able to perform autologous donation? (a) 100 lbs (b) 14
yrs old (c) Hgb 12 g/dL (d) Mild bacteremia
293.
Why should patients RBCs be washed after DAT? (a) prevent hemolysis (b) prevent
neutralization (c) prevent pseudoagglutination (d) to remove RBCs
294.
A woman who had a baby 2 months ago wishes to donate blood for allogenic
transfusion: (a) defer temporarily (b) defer for 1 year (c) defer indefinitely (d) accept